Point Of Care Diagnostic Devices Market
Point-of-Care Diagnostic Devices Market Forecasts to 2034 - Global Analysis By Product Type (Glucose Monitoring Devices, Infectious Disease Testing Devices, Cardiac Marker Testing Devices, Blood Gas & Electrolyte Analyzers and Other Product Types), Sample Type, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Point-of-Care Diagnostic Devices Market is accounted for $48 billion in 2026 and is expected to reach $85 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Point-of-Care Diagnostic Devices are portable medical tools used to perform diagnostic tests at or near the site of patient care. These devices provide rapid results for conditions such as infections, blood glucose levels, cardiac markers, and more, enabling immediate clinical decisions. They reduce the need for centralized laboratory testing and improve efficiency in healthcare delivery. Widely used in hospitals, clinics, and home settings, point-of-care devices support early diagnosis, timely treatment, and improved patient outcomes, particularly in emergency and remote care environments.
Market Dynamics:
Driver:
Increasing prevalence of chronic diseases
Rising cases of diabetes, cardiovascular disorders, and infectious diseases have created urgent demand for rapid, accurate, and accessible diagnostic solutions. Point-of-care devices enable immediate testing and results, supporting timely clinical decisions and reducing hospital visits. Their portability and ease of use make them suitable for both clinical and home settings. Healthcare providers are increasingly adopting these devices to improve patient outcomes and reduce the burden on centralized laboratories. The growing global burden of chronic illnesses is expected to sustain strong demand for point-of-care diagnostics.
Restraint:
Regulatory approval challenges
Stringent requirements for clinical validation, safety, and accuracy often delay product launches. Manufacturers face complex approval processes across different regions, which increases costs and slow global expansion. Smaller companies, in particular, struggle to navigate these regulatory hurdles, limiting innovation. Healthcare providers may hesitate to adopt new devices until they receive full regulatory clearance, further slowing uptake. While regulatory bodies aim to ensure patient safety, the lengthy approval timelines remain a barrier to rapid commercialization.
Opportunity:
Integration with digital health platforms
Linking devices with mobile apps, electronic health records, and telehealth platforms enhances data accessibility and patient monitoring. Physicians can remotely track patient results, enabling proactive interventions and personalized treatment plans. Patients benefit from improved convenience and engagement, as results can be shared instantly with healthcare providers. This integration also supports population health management and chronic disease monitoring at scale. Companies are increasingly investing in connected diagnostics to align with digital health trends. As healthcare systems embrace digital-first models, integration opportunities are expected to drive significant growth.
Threat:
Pricing pressure from low-cost devices
Many local manufacturers in emerging economies offer affordable point-of-care solutions, challenging established players. Price-sensitive markets often prioritize cost over advanced features, limiting margins for premium products. This competitive environment forces companies to balance innovation with affordability. Healthcare providers may opt for cheaper alternatives, even if they lack advanced connectivity or analytics. The threat of commoditization is particularly strong in segments such as glucose monitoring and rapid infectious disease tests.
Covid-19 Impact:
The COVID-19 pandemic significantly accelerated the adoption of point-of-care diagnostic devices. Rapid testing became essential for managing infection spread, driving unprecedented demand for portable diagnostic solutions. Governments and healthcare systems invested heavily in point-of-care testing infrastructure during the crisis. The pandemic also highlighted the importance of decentralized diagnostics, reducing reliance on centralized laboratories. Post-pandemic, the momentum continues as healthcare providers recognize the value of rapid diagnostics for chronic disease management and emergency care. Manufacturers are leveraging lessons from COVID-19 to expand product portfolios and strengthen supply chains.
The immunoassays segment is expected to be the largest during the forecast period
The immunoassays segment is expected to account for the largest market share during the forecast period as the increasing prevalence of chronic diseases has heightened demand for rapid and accurate biomarker detection. Immunoassays are widely used for diagnosing infectious diseases, monitoring chronic conditions, and detecting cancer markers. Their versatility and reliability make them a cornerstone of point-of-care diagnostics. Advances in microfluidics and portable platforms are enhancing the efficiency of immunoassays. Hospitals, clinics, and home care settings increasingly rely on these tests for immediate decision-making. The segment benefits from strong demand across both developed and emerging markets.
The home care settings segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home care settings segment is predicted to witness the highest growth rate due to the increasing prevalence of chronic diseases, which has driven demand for convenient, at-home diagnostic solutions. Patients with diabetes, cardiovascular disorders, and respiratory conditions increasingly rely on point-of-care devices for self-monitoring. Home-based diagnostics reduce hospital visits, improve adherence, and empower patients to manage their health. The segment benefits from growing adoption of connected devices that integrate with mobile apps and telehealth platforms. Rising healthcare costs and aging populations further support the shift toward home care. Manufacturers are focusing on user-friendly, portable devices tailored for home use.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure and the increasing prevalence of chronic diseases across the population. The U.S. leads in adoption of point-of-care diagnostics, supported by strong reimbursement frameworks and regulatory approvals. Major players in the market are headquartered in the region, driving innovation and commercialization. High incidence of diabetes, cardiovascular disorders, and cancer fuels demand for rapid diagnostics. The region also benefits from strong integration of digital health platforms with point-of-care devices. Ongoing investments in R&D and clinical trials further strengthen market leadership.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare digitization and the increasing prevalence of chronic diseases in emerging economies. Countries such as China, India, and Southeast Asia are witnessing rising demand for affordable and accessible diagnostics. Governments are investing in healthcare infrastructure and promoting decentralized testing to improve equity. Local manufacturers are offering cost-effective solutions, boosting adoption in price-sensitive markets. Growing smartphone penetration and telehealth initiatives enhance integration of point-of-care devices with digital platforms. Rising awareness of preventive healthcare further supports market expansion.
Key players in the market
Some of the key players in Point-of-Care Diagnostic Devices Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories, QuidelOrtho Corporation, PerkinElmer Inc., Sekisui Diagnostics, Trinity Biotech, Arkray Inc., SD Biosensor Inc., Werfen, Hologic Inc. and Fujifilm Holdings Corporation.
Key Developments:
In March 2026, Arkray launched a portable HbA1c analyzer for diabetes management in outpatient clinics. The device provides immediate results, enabling clinicians to adjust treatment plans during patient visits. Arkray’s innovation reinforces its focus on chronic disease management through point-of-care solutions.
In September 2025, Bio-Rad introduced a compact immunoassay analyzer for decentralized oncology testing. The system supports biomarker-guided therapy decisions, offering clinicians rapid results outside central labs. Bio-Rad’s innovation reflects its focus on precision diagnostics and expanding access to personalized medicine tools.
In June 2025, Sekisui Diagnostics launched a rapid point-of-care test for C-reactive protein (CRP), supporting infection and inflammation management. The device offers results in under five minutes, aiding primary care decision-making. Sekisui’s expansion into portable immunoassays strengthens its role in frontline diagnostics.
Product Types Covered:
• Glucose Monitoring Devices
• Infectious Disease Testing Devices
• Cardiac Marker Testing Devices
• Blood Gas & Electrolyte Analyzers
• Other Product Types
Sample Types Covered:
• Blood
• Urine
• Saliva
• Nasal/Throat Swabs
• Other Sample Types
Technologies Covered:
• Lateral Flow Assays
• Immunoassays
• Molecular Diagnostics
• Microfluidics
• Biosensors
• Other Technologies
Applications Covered:
• Diabetes Testing
• Cardiovascular Diseases
• Oncology Testing
• Pregnancy & Fertility Testing
• Other Applications
End Users Covered:
• Hospitals
• Clinics
• Diagnostic Centers
• Home Care Settings
• Other End Users
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Point-of-Care Diagnostic Devices Market, By Product Type
5.1 Glucose Monitoring Devices
5.2 Infectious Disease Testing Devices
5.3 Cardiac Marker Testing Devices
5.4 Blood Gas & Electrolyte Analyzers
5.5 Other Product Types
6 Global Point-of-Care Diagnostic Devices Market, By Sample Type
6.1 Blood
6.2 Urine
6.3 Saliva
6.4 Nasal/Throat Swabs
6.5 Other Sample Types
7 Global Point-of-Care Diagnostic Devices Market, By Technology
7.1 Lateral Flow Assays
7.2 Immunoassays
7.3 Molecular Diagnostics
7.4 Microfluidics
7.5 Biosensors
7.6 Other Technologies
8 Global Point-of-Care Diagnostic Devices Market, By Application
8.1 Diabetes Testing
8.2 Cardiovascular Diseases
8.3 Oncology Testing
8.4 Pregnancy & Fertility Testing
8.5 Other Applications
9 Global Point-of-Care Diagnostic Devices Market, By End User
9.1 Hospitals
9.2 Clinics
9.3 Diagnostic Centers
9.4 Home Care Settings
9.5 Other End Users
10 Global Point-of-Care Diagnostic Devices Market, By Geography
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 United Kingdom
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Netherlands
10.2.7 Belgium
10.2.8 Sweden
10.2.9 Switzerland
10.2.10 Poland
10.2.11 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Thailand
10.3.8 Malaysia
10.3.9 Singapore
10.3.10 Vietnam
10.3.11 Rest of Asia Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Colombia
10.4.4 Chile
10.4.5 Peru
10.4.6 Rest of South America
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.1.1 Saudi Arabia
10.5.1.2 United Arab Emirates
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 Rest of Middle East
10.5.2 Africa
10.5.2.1 South Africa
10.5.2.2 Egypt
10.5.2.3 Morocco
10.5.2.4 Rest of Africa
11 Strategic Market Intelligence
11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment
12 Industry Developments and Strategic Initiatives
12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives
13 Company Profiles
13.1 Abbott Laboratories
13.2 Roche Diagnostics
13.3 Siemens Healthineers
13.4 Danaher Corporation
13.5 Becton Dickinson and Company
13.6 Bio-Rad Laboratories
13.7 QuidelOrtho Corporation
13.8 PerkinElmer Inc.
13.9 Sekisui Diagnostics
13.10 Trinity Biotech
13.11 Arkray Inc.
13.12 SD Biosensor Inc.
13.13 Werfen
13.14 Hologic Inc.
13.15 Fujifilm Holdings Corporation
List of Tables
1 Global Point-of-Care Diagnostic Devices Market Outlook, By Region (2023-2034) ($MN)
2 Global Point-of-Care Diagnostic Devices Market, By Product Type (2023–2034) ($MN)
3 Global Point-of-Care Diagnostic Devices Market, By Glucose Monitoring Devices (2023–2034) ($MN)
4 Global Point-of-Care Diagnostic Devices Market, By Infectious Disease Testing Devices (2023–2034) ($MN)
5 Global Point-of-Care Diagnostic Devices Market, By Cardiac Marker Testing Devices (2023–2034) ($MN)
6 Global Point-of-Care Diagnostic Devices Market, By Blood Gas & Electrolyte Analyzers (2023–2034) ($MN)
7 Global Point-of-Care Diagnostic Devices Market, By Other Product Types (2023–2034) ($MN)
8 Global Point-of-Care Diagnostic Devices Market, By Sample Type (2023–2034) ($MN)
9 Global Point-of-Care Diagnostic Devices Market, By Blood (2023–2034) ($MN)
10 Global Point-of-Care Diagnostic Devices Market, By Urine (2023–2034) ($MN)
11 Global Point-of-Care Diagnostic Devices Market, By Saliva (2023–2034) ($MN)
12 Global Point-of-Care Diagnostic Devices Market, By Nasal/Throat Swabs (2023–2034) ($MN)
13 Global Point-of-Care Diagnostic Devices Market, By Other Sample Types (2023–2034) ($MN)
14 Global Point-of-Care Diagnostic Devices Market, By Technology (2023–2034) ($MN)
15 Global Point-of-Care Diagnostic Devices Market, By Lateral Flow Assays (2023–2034) ($MN)
16 Global Point-of-Care Diagnostic Devices Market, By Immunoassays (2023–2034) ($MN)
17 Global Point-of-Care Diagnostic Devices Market, By Molecular Diagnostics (2023–2034) ($MN)
18 Global Point-of-Care Diagnostic Devices Market, By Microfluidics (2023–2034) ($MN)
19 Global Point-of-Care Diagnostic Devices Market, By Biosensors (2023–2034) ($MN)
20 Global Point-of-Care Diagnostic Devices Market, By Other Technologies (2023–2034) ($MN)
21 Global Point-of-Care Diagnostic Devices Market, By Application (2023–2034) ($MN)
22 Global Point-of-Care Diagnostic Devices Market, By Diabetes Testing (2023–2034) ($MN)
23 Global Point-of-Care Diagnostic Devices Market, By Cardiovascular Diseases (2023–2034) ($MN)
24 Global Point-of-Care Diagnostic Devices Market, By Oncology Testing (2023–2034) ($MN)
25 Global Point-of-Care Diagnostic Devices Market, By Pregnancy & Fertility Testing (2023–2034) ($MN)
26 Global Point-of-Care Diagnostic Devices Market, By Other Applications (2023–2034) ($MN)
27 Global Point-of-Care Diagnostic Devices Market, By End User (2023–2034) ($MN)
28 Global Point-of-Care Diagnostic Devices Market, By Hospitals (2023–2034) ($MN)
29 Global Point-of-Care Diagnostic Devices Market, By Clinics (2023–2034) ($MN)
30 Global Point-of-Care Diagnostic Devices Market, By Diagnostic Centers (2023–2034) ($MN)
31 Global Point-of-Care Diagnostic Devices Market, By Home Care Settings (2023–2034) ($MN)
32 Global Point-of-Care Diagnostic Devices Market, By Other End Users (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
